Zheng, Xuhui
Marsman, Gerben http://orcid.org/0000-0002-5376-8000
Lacey, Keenan A. http://orcid.org/0000-0002-9242-0170
Chapman, Jessica R. http://orcid.org/0000-0002-4080-8667
Goosmann, Christian
Ueberheide, Beatrix M.
Torres, Victor J. http://orcid.org/0000-0002-7126-0489
Funding for this research was provided by:
Max-Planck-Gesellschaft
Cystic Fibrosis Foundation (LACEY19FO)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI099394, R01 AI105129, R01 AI140754, HHSN272201400019C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Burroughs Wellcome Fund
Article History
Received: 27 October 2020
Accepted: 5 October 2021
First Online: 26 October 2021
Competing interests
: V.J.T. is an inventor on patents and patent applications filed by New York University, which are currently under commercial license to Janssen Biotech Inc. (patent nos. US10669329; US10202440; US10087243; MY-175062-A; BR112013032774-0; 60 2014 068 192.1; 40000719B; 1190640B9; 10-2050267; 2012273125; 2012273123; 10,781,246; 10,301,378; 9,783,597; 9,657,103; 9,644,023; 9,481,723; 9,480,726; 9,091,689; 8,846,609; 6758363; 6452765; 6,170,913; 6,093,760; 3441474; 3403669; 3011012; 2,720,754; 2720714; 2,635,462; 2,613,135; 2,609,650; 730359; 710,439; 619,942; 619,938; 357,938; 343,589; 340,446; and 229922). Janssen Biotech Inc. provides research funding and other payments associated with the licensing agreement. All other authors declare no conflicts of interest.